Literature DB >> 7715945

Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats.

Annika B Malmberg1, Tony L Yaksh.   

Abstract

The effect of continuous intrathecal infusion of omega-conopeptides in the rat was examined to determine whether antinociception, as measured on the formalin and hot-plate (52.5 degrees C) tests, was altered and whether tolerance developed with chronic infusion of these agents. Infusion of 0.030 and 0.003 nmol/h SNX-111 and 0.290 nmol/h SNX-239 was performed for either 2 days ('acute') or 7 days ('chronic') and was compared to the effect of 20 nmol/h morphine or saline. Both doses of SNX-111 and SNX-239 produced a significant reduction of the response to the hot-plate and formalin tests at both 2 and 7 days of infusion compared to saline infusion. In contrast, morphine only produced a significant effect on day 2, but not on infusion day 7, indicating that tolerance had developed. The effect of SNX-111 was reversible, as shown by a return to nociceptive responses similar to saline-infused rats 2 days after the minipumps had been disconnected after a 7-day infusion period. These data indicate that chronic infusion of omega-conopeptides that block N-type voltage-sensitive calcium channels produce a powerful antinociception, with minimal development of tolerance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715945     DOI: 10.1016/0304-3959(94)00094-U

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  38 in total

Review 1.  Environment and health: 7. Species loss and ecosystem disruption--the implications for human health.

Authors:  E Chivian
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

Review 2.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain.

Authors:  Quinn H Hogan
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

4.  Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

Authors:  A Jayamanne; H J Jeong; C I Schroeder; R J Lewis; M J Christie; C W Vaughan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Subarachnoid Techniques for Cancer Pain Therapy: When, Why, and How?

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 6.  Use of venom peptides to probe ion channel structure and function.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

7.  Black mamba venom peptides target acid-sensing ion channels to abolish pain.

Authors:  Sylvie Diochot; Anne Baron; Miguel Salinas; Dominique Douguet; Sabine Scarzello; Anne-Sophie Dabert-Gay; Delphine Debayle; Valérie Friend; Abdelkrim Alloui; Michel Lazdunski; Eric Lingueglia
Journal:  Nature       Date:  2012-10-03       Impact factor: 49.962

8.  Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.

Authors:  Maciej Gasior; Natalie A White; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2007-08-23       Impact factor: 4.030

Review 9.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 10.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.